Adagene Inc.
USD4.26
+0.03 (+0.71%)
CEO
Peter Luo
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CN
Open
$4.22
Prev. Close
$4.23
Day Low
$4.10
Day High
$4.50
52W Low
$1.30
52W High
$4.75
Market Cap
$0.16B
Volume
0.25M
| -2.1 |
| 31 Dec 2023 | FY | 100.0% | -104.6% | -26.9% | -16.4% | 0.32 | 3.61 | -3.5 |
| 31 Dec 2022 | FY | 100.0% | -860.6% | -96.2% | -52.5% | 0.34 | 2.71 | -0.6 |
| 31 Dec 2021 | FY | 100.0% | -719.2% | -46.7% | -38.6% | 0.05 | 6.24 | -3.5 |
| 31 Dec 2020 | FY | 100.0% | -3424.1% | 18.4% | -19.5% | -0.09 | 4.90 | -51.2 |
| 31 Dec 2019 | FY | 100.0% | -3602.9% | 30.3% | -16.3% | -0.04 | 14.47 | -61.3 |
| 31 Dec 2018 | FY | 100.0% | -974.0% | 35.9% | -27.0% | -0.06 | 5.01 | -19.8 |
| -1.4 |
| 31 Dec 2024 | Q4 | -797.5% | -24144.7% | -49.3% | -27.9% | 0.37 | 2.30 | -0.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -15.0% | -8.4% | 0.37 | 2.50 | -3.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.0% | -8.4% | 0.37 | 2.50 | -3.3 |
| 31 Dec 2023 | Q4 | -4.3% | -1818.9% | -10.5% | -6.4% | 0.32 | 3.61 | -2.3 |
| 30 Sept 2023 | Q3 | 100.0% | -1818.9% | -10.5% | -6.4% | 0.32 | 3.61 | -1.8 |
| 30 Jun 2023 | Q2 | 0.0% | -23.8% | -2.5% | -1.5% | 0.30 | 3.40 | -5.9 |
| 31 Mar 2023 | Q1 | 100.0% | -23.8% | -2.5% | -1.5% | 0.30 | 3.40 | -5.8 |
| 31 Dec 2022 | Q4 | 0.9% | -602.1% | -19.5% | -10.6% | 0.34 | 2.71 | -0.7 |